DC Field | Value | Language |
dc.contributor.author | Kononov, S. | - |
dc.contributor.author | Azarova, L. | - |
dc.contributor.author | Klyosova, E. | - |
dc.contributor.author | Bykanova, M. | - |
dc.contributor.author | Churnosov, M. | - |
dc.date.accessioned | 2024-03-29T12:30:57Z | - |
dc.date.available | 2024-03-29T12:30:57Z | - |
dc.date.issued | 2023 | - |
dc.identifier.citation | Lipid-Associated GWAS Loci Predict Antiatherogenic Effects of Rosuvastatin in Patients with Coronary Artery Disease / S. Kononov, L. Azarova, E. Klyosova [et al.] // Genes. - 2023. - Vol.14, №6.-Art. 1259. | ru |
dc.identifier.uri | http://dspace.bsu.edu.ru/handle/123456789/61823 | - |
dc.description.abstract | We have shown that lipid-associated loci discovered by genome-wide association studies (GWAS) have pleiotropic effects on lipid metabolism, carotid intima-media thickness (CIMT), and CAD risk. Here, we investigated the impact of lipid-associated GWAS loci on the efficacy of rosuvastatin therapy in terms of changes in plasma lipid levels and CIMT | ru |
dc.language.iso | en | ru |
dc.subject | medicine | ru |
dc.subject | medical genetics | ru |
dc.subject | coronary artery disease | ru |
dc.subject | plasma lipids | ru |
dc.subject | carotid intima-media thickness | ru |
dc.subject | pharmacogenetics | ru |
dc.subject | personalized medicine | ru |
dc.subject | single nucleotide polymorphisms | ru |
dc.subject | lipid-lowering therapy | ru |
dc.subject | rosuvastatin | ru |
dc.title | Lipid-Associated GWAS Loci Predict Antiatherogenic Effects of Rosuvastatin in Patients with Coronary Artery Disease | ru |
dc.type | Article | ru |
Appears in Collections: | Статьи из периодических изданий и сборников (на иностранных языках) = Articles from periodicals and collections (in foreign languages)
|